Amcor plc (NYSE:AMCR) Q3 2024 Earnings Call Transcript

Amcor plc (NYSE:AMCR) Q3 2024 Earnings Call Transcript April 30, 2024

Amcor plc misses on earnings expectations. Reported EPS is $0.1299 EPS, expectations were $0.17. Amcor plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Thank you for standing by. My name is Jay and I will be your conference operator today. At this time, I would like to welcome everyone to the Amcor Third Quarter 2024 Results Call. [Operator Instructions] I would now like to turn the conference over to Tracey Whitehead, Head of Investor Relations. You may begin.

Tracey Whitehead: Thank you, operator and thank you everyone for joining Amcor’s fiscal 2023 third quarter earnings call. Joining today is Peter Konieczny, Interim Chief Executive Officer; and Michael Casamento, Chief Financial Officer. Before I hand over, a few items to note. On our website, amcor.com, under the Investors section, you’ll find today’s press release and presentation, which we will discuss on this call. Please be aware that we’ll also discuss non-GAAP financial measures and related reconciliations can be found in that press release and the presentation. Remarks will also include forward-looking statements that are based on management’s current views and assumptions. The second slide in today’s presentation lists several factors that could cause future results to be different than current estimates.

Reference can also be made Amcor’s SEC filings, including our statements on Form 10-K and 10-Q for further details. [Operator Instructions] With that, over to you, P.K.

Peter Konieczny: Thank you, Tracey and thank you to all who have joined us for today’s call. Prior to discussing our third quarter performance, I want to spend a few moments recognizing my predecessor, Ron Delia, and his many accomplishments at Amcor. In the last few years alone, Ron led us through the transformational acquisition and integration of Bemis, the largest acquisition in the company’s history, successfully and safely guided the business through a pandemic and made the difficult and correct decision to divest our business in Russia. And most recently, Ron directed our teams in navigating that particularly challenging economic period. I now will speak for the Board, our global management team and our employees around the world and thanking Ron for his leadership, guidance and dedication during his 18 years with Amcor and 9 years as CEO.

I’ve worked closely with Ron, our board and the other members of our executive team over many years to help shape and execute our strategy, and I am honored to take the leadership reigns in an interim capacity at this time. Today, Amcor is the established industry leader in our key markets and geographies, has world class talent and clearly differentiated commercial innovation capabilities, all providing us with multiple opportunities to capture high value growth. Importantly, the business is also well positioned to continue benefiting from the proactive steps taken by our leaders across the company to align the cost base with recent challenging market conditions. The results of those decisive actions were again evident in our third quarter financial performance as we showed strong earnings leverage across the business.

Third quarter year-over-year volume performance also improved on a sequential basis, and we expect this trend to continue driving stronger earnings growth as we close fiscal year ‘24. My role right now is to ensure we stay focused and on track and that we capitalize on the strong position we are in to maintain momentum and further accelerate earnings growth. It is a team effort and will drive success. And I am surrounded and supported by credible leaders and talented team players throughout our organization. As seen on Slide 3, my near-term priorities are simple. First, ensure Amcor continues to provide a safe and healthy work environment for our global workforce. Second, stay close to our key stakeholders, including our employees and customers and finish our 2024 fiscal year strongly.

After an improved third quarter performance, we are well positioned to do so and we’ve raised our full year guidance today. Third, build on the momentum we have worked hard to deliver across the business and as we work through our planning cycle for fiscal ‘25 set clear priorities to ensure our momentum continues. And fourth, provide stability for the business and keep our teams focused on delivering for all our stakeholders by reinforcing that. Our strategy has not changed, our agenda has not changed, and our priorities have not changed. Moving to Amcor’s Q3 performance, starting with safety on Slide 4. Our commitment to health and safety of our teams remains our number one priority, and we continue to focus on providing a safe and healthy work environment.

72% of our sites have been injury-free for the past 12 months or longer, and we experienced a 19% reduction in injuries compared to the first 9 months of fiscal ‘23. Safety is deeply embedded in Amcor’s culture and is a critical cornerstone of our success. Turning to our key messages for today on Slide 5. First, outperformance in the underlying business resulted in adjusted earnings per share for the third quarter that exceeded the expectations we set out in February. Our Flexibles and Rigid Packaging segment each delivered adjusted EBIT growth, leading to Amcor returning to year-over-year earnings growth a quarter sooner than we anticipated. Improved working capital performance through the year also resulted in a year-to-date increase in adjusted free cash flow.

Second, as I mentioned earlier, our third quarter volume trajectory improved significantly on a sequential basis as destocking abated across most end markets, and we experienced higher customer demand in several of our businesses. While this is clearly an encouraging and positive trend, our teams remain highly focused on continuing to control costs and this helped us deliver a third consecutive quarter of improved earnings leverage and a return to earnings growth. Third, our March quarter financial performance and expected further momentum in our fourth quarter gives us the confidence to increase our full year adjusted EPS guidance range to $0.685 to $0.71 per share and reaffirm our guidance for adjusted free cash flow between $850 million and $950 million for the fiscal year.

We believe we have turned the corner after a challenging calendar 2023, and we expect our sequential volume and earnings growth trajectories will continue to improve, which is supported by the demand trends experienced across the business in the first weeks of April. Finally, we remain confident in our capital allocation framework and strategy for long-term growth. We believe the strength of our market positions, our opportunities for investment and our execution capabilities, along with our commitment to a compelling and growing dividend, make a convincing investment case for Amcor. Moving to Slide 6 for a summary of our financial results. The first 9 months of fiscal ‘24 continued to reflect significant benefits from our proactive cost actions.

Three consecutive quarters of strong operating leverage helped offset the unfavorable impact of 7% lower sales – lower year-to-date sales, leading to a decline in adjusted EBIT of 3%. We believe we’ve reached an inflection point in the trajectory of earnings and volumes with our Q3 results, and we are pleased with our financial results in the March quarter. Better-than-anticipated demand trends and continued strong cost performance resulted in EBIT and earnings per share ahead of our expectations entering the quarter. The underlying business saw a return to profit growth in the third quarter with adjusted EBIT of 3% compared with last year. Volume trends improved as the broad-based destocking experienced in the December quarter abated and customer demand strengthened.

Our teams also continue to focus on cost reduction and productivity initiatives and delivered another quarter of outstanding results with approximately $130 million in total cost savings, including approximately $15 million of benefit from structural cost initiatives. These benefits, combined with improving volume trends, resulted in another quarter of improved earnings leverage. Interest and tax expects were modestly higher than the prior year, in line with our expectations and adjusted earnings per share of $0.178, grew by 1%. Q3 net sales were down 6% on a comparable constant currency basis, which primarily reflects overall volumes 4% lower than the prior year. This is predominantly related to expected ongoing weakness, including further destocking in healthcare categories and in the North American beverage business, which collectively represent approximately 3% of Amcor’s total sales.

Across the remaining 70% of our business, overall net volumes were relatively flat with last year, a significant improvement compared with the December quarter and the business delivered volume growth across several categories and geographies. Outside of healthcare, we believe destocking is now largely behind us. Price mix for Q3 had an unfavorable impact on sales of approximately 3%, which is a result of greater volume declines in high-margin healthcare categories, which we anticipated and called out last quarter. We continue to return significant cash to shareholders through a compelling and growing dividend and share repurchases, which totaled approximately $570 million through the first 9 months of the year. I’ll turn it over to Michael now to provide some further color on the financials and our outlook.

Michael Casamento: Thanks, PK, and hello, everyone. Beginning with the Flexibles segment on Slide 7 and focusing on our Q3 performance. Net sales for Q3 were down 6%, reflecting an unfavorable pricing impact of 4% and a 2% decline in overall volumes, which was a significant improvement of 8 percentage points compared with the December quarter. As we anticipated and called out last quarter, volumes for healthcare products remained weak and destocking continued, particularly in North America and Europe. In total, healthcare volumes were down double digits, and this had an unfavorable impact of approximately 3% on overall segment volumes and was the primary driver of the 4% unfavorable mix in the quarter. Across the balance of our flexibles portfolio, net volumes grew approximately 1% in the quarter, with growth in several end markets, including meat, pet food, cheese and unconverted film foil, and we also saw growth across a number of emerging markets.

Across North America and Europe, third quarter net sales decline a high-single-digit rates and favorably impacted by a mid-single-digit lower volumes and unfavorable price/mix related decline in healthcare categories. Excluding healthcare across these two regions, we saw mid-single volume growth in cheese and a strong sequential improvement in meat and pet care volumes, which were flat and up low-single digits for the quarter, respectively. Across the Asian region, net sales were modestly higher than the prior year. China grew volumes for the third consecutive quarter. And volume growth in Thailand, India and the Philippines also helped offset lower volumes in South East Asian healthcare business. In Latin America, the business delivered good volume growth in Brazil, Mexico and Peru.

Q3 adjusted EBIT of $358 million, was 5% higher than last year on a comparable constant currency basis. Strong cost performance through the quarter, including from restructuring initiatives, combined with broadly improving demand trends, led to another quarter of strong earnings leverage, and EBIT margins increased by 170 basis points to 13.8%. Turning to Rigid Packaging on Slide 8. Q3 net sales were 8% lower on a comparable constant currency basis, mainly reflecting lower volumes. While overall volumes were down 8% for the quarter, this represents a meaningful improvement over the December quarter. In North America, overall beverage volumes continue to be impacted by soft consumer and customer demand in Amcor’s key end markets, along with some lingering destocking.

Total beverage volumes were down 11%, improving sequentially from the 19% decline we experienced in December quarter, which was impacted by significantly more destocking. Latin America volumes were in line with last year with growth in Brazil and Colombia, offset by weaker demand in Argentina. We are pleased to see the Rigid Packaging business return to earnings growth, with adjusted third quarter EBIT up modestly over last year. Strong earnings leverage resulting from a continued focus on cost reduction and productivity measures and the realization of benefits from restructuring initiatives more than offset lower volumes, leading to an 80 basis point increase in EBIT margins to 8.7% for the quarter. Moving to cash and the balance sheet on Slide 9.

Adjusted free cash flow for the first 9 months was approximately $100 million ahead of last year, mainly driven by improved working capital performance and successfully reducing inventory levels for the fifth consecutive quarter. Leverage at 3.4x is broadly in line with the first half and within the range of expected outcomes for the third quarter. As a reminder, the business is cycling through temporary increases in working capital, and trailing 12-month EBITDA remains at lower than historic levels, reflecting the divestiture of our Russian business in December 2022. Looking ahead, we continue to expect leverage will decrease to approximately 3x at the end of our fiscal year, supported by seasonally stronger earnings and cash flow in our fiscal fourth quarter.

This brings me to our outlook on Slide 10. As P.K. noted earlier, we are raising our full year guidance for adjusted EPS to $0.685 to $0.71 per share to reflect our performance in the underlying business in the third quarter and our expectation that volumes will continue to improve through the balance of the year. We also remain focused on controlling costs and expect to deliver further savings in Q4, including from our structural initiatives. For fiscal 2024, we continue to expect the underlying business to contribute organic earnings growth in the plus/minus low single-digit range with share repurchases adding a benefit of approximately 2% and favorable currency translation contributing a benefit of up to 2%. This is offset by negative impact of approximately 3% related to the sale of our Russian business in December 2022.

The impact of which was all in the first half. We also expect a negative impact of up to 6% from higher interest and tax expense, which takes into account our updated estimate for the full year net interest expense of between $310 million to $320 million. We are confident, we will build on our third quarter performance, and adjusted earnings per share for the fourth quarter is expected to grow over last year by mid-single digits on a comparable constant currency basis. And overall volumes in the fourth quarter are expected to be down in the low single-digit range, primarily due to ongoing destocking in healthcare categories and continued weak consumer and customer demand in North America beverage. We expect the volume improvement we experienced in the third quarter to continue as we progress through the fourth quarter, which will position us well as we enter fiscal 2025.

We have also reaffirmed our guidance range for adjusted free cash flow of $850 million to $950 million for the year. So with that, I’ll hand back to P.K.

Peter Konieczny: Thank you, Michael. In closing, on Slide 11, our Q3 financial results guidance for the balance of the fiscal year and our expectation that we will continue to build earnings momentum in fiscal ‘25 will highlight that Amcor is a very well-positioned business. Amcor’s industry leadership across the globe is well established. Our differentiated innovation capabilities are assisting the world’s best known brands and smaller companies in achieving their objectives to protect, preserve and promote their products while enabling them to meet the sustainability commitments they have made to the stakeholders. And Amcor’s talented employees around the world are capitalizing on growth opportunities in priority categories, emerging markets and through sustainable offerings while also continuing to closely focus on cost controls.

We’re confident we will continue to see positive momentum given the actions we have taken and continue to take across our operations to invest in growth, reduce cost and improve productivity. As I mentioned at the beginning of the call, my role right now is to ensure we stay focused and on track and that we capitalize on the strong position we are in to maintain momentum and further accelerate earnings growth. The continued safety of our goal will always be at the top of Amcor’s agenda. But a very close second for me right now is to keep our teams focused on delivering for all our stakeholders by reinforcing that our strategy, our agenda and our priorities have not changed. Our Q3 volume trajectory and financial performance underscores our confidence in stronger earnings growth momentum as the challenges we faced in calendar ‘23 are put further behind us.

We have raised our full year EPS guidance, and we anticipate delivering mid-single-digit earnings growth in Q4. Our performance in the first few weeks of April supports this expectation. And our commitments to our longer-term growth and value creation strategy gives us line of sight to a return to growth in line with our shareholder value creation model. Operator, we’re now ready to turn the line over to questions.

Operator: Thank you. [Operator Instructions] Your first question comes from the line of Ghansham Panjabi of Baird. Your line is open.

See also Jim Cramer is Recommending These 10 Stocks Heading Into May 2024 and Democrats and Corporate Insiders are Buying These 10 Stocks.

Q&A Session

Ghansham Panjabi: Hi, guys. How are you? I guess first off, it just sounds like volume surprised you to the upside during your third quarter. Do you think that’s just a function of 2Q coming in lower than forecast just given aggressive year-end inventory destocking by your customers? What do you think this is more of a sustainable improvement that you’re going to build upon as you look out to your fiscal year ‘25? Thanks.

Peter Konieczny: Yes, thanks. It’s a great question. I mean there is a couple of things to take away here from the discussion of the quarter. The first one really is that the volumes improved. The second one is that we had great cost performance. And the third one really is that we believe the momentum carries over into the Q4. But let me get back to the volume question. So significant improvement sequentially on volumes from the second to the third quarter, to remind ourselves, second quarter, we were down 10%. Third quarter, we were coming in 4% down versus prior year. And when you look at the 4% that we were down, it pretty much equally split between two drivers. That’s the market impacts. And by that, I mean consumer demand and our exposure to categories and customers.

And then the second one is destocking. So that made up the 4% decline. And when you – and another way to look at that is the 4% decline was pretty much all driven by destocking in healthcare and North American beverage. That also means that the balance of the portfolio ended up being pretty flat. And we’re pretty much pleased with this outcome because when you think about it, healthcare and North American beverage is about 30% of our business, that means the balance of the portfolio, 70% came in flat. Now when I take a step back and we look at the third quarter volume performance, now there’s a few things that we take away. The first one is, we saw a bit of unwind of a very strong destocking in the December month. And when we discussed the second quarter, we talked about a pretty strong January.

And there was a bit of a question mark around how much of that performance was driven by unwind of the December month. And as we sort of left Q3 behind us, we can confirm that the volumes in January and also February, to a certain extent, benefited from a bit of an unwind in an unusually low December month. So that was the first one. But the second thing that we’ve seen is that our customers perform better. And we talked about that also in the last quarter. The background here is that customers are – particularly large customers are talking more and more and responding more and more towards turning the dial a bit towards a better balance between volumes and margins. So we’ve seen that come through. And then the third one is pretty much what we expected to a certain extent that the destocking would abate.

And that pretty much happened with the exception of healthcare and some lingering destocking in North American beverage. So look, that’s pretty much the discussion of the third quarter. But as I have the floor on volumes, let me just make two more comments and breaking it down into the segments here because I think the color is important. In Flexibles, we came from being 10% down in the second quarter to being 2% down in the third quarter. And again, the customer performance sort of drove improved market impact performance and then the destocking significantly abated. And when you look at the Flexibles segment, it was all made up by the healthcare impact in terms of the decline, the balance of the portfolio is flat to even slightly up. And then just one more comment on Rigid and then I’ll stop.

Rigid went from 12% down in the second quarter to 8% down in the third quarter, so also an improvement. We continue to see a soft market, but the destocking as significantly rated in Rigids also. So across the board, really, really good improvement. And when you think back to what I discussed, there’s components in where the – that we believe to be sustainable, no question. And that relates to one further abatement of the destocking and second, to good customer performance that we continue – that we believe we will continue to see people.

Operator: Your next question comes from the line of Daniel Kang of CLSA. Your line is open.

Daniel Kang: Good morning, Peter. Good morning, Michael. Just a question on healthcare. You mentioned healthcare continued to fall double digits in 3Q, which from memory sounds quite similar to the December quarter. Can you comment on whether there was any sequential improvement in 3Q? And just from the visibility of customer stock levels and given the low comps that you should be working with going forward, is it reasonable to expect that first half fiscal year ‘25 to show some improvement in healthcare bond?

Peter Konieczny: Let me help you with healthcare a bit. So the main driver of the healthcare performance really has been the destocking and the destocking sort of abating from Q2 to Q3. I would say, overall, the demand situation has not really changed much in healthcare. So you would see overall healthcare is marginally better between the second and the third quarter. We do expect further improvement in healthcare though because the destocking will further sort of reduce in the fourth quarter. As a matter of fact, when we guide to low single-digit volume decline in the fourth quarter, we would believe that most of that is driven by healthcare – all of that is driven by healthcare. And we don’t really know exactly when the destocking will come to an end.

It will certainly sort of stretch into the fourth quarter. Maybe we’ll see a bit of an – we see a bit of an impact also in the first quarter of fiscal ‘25. But that would be as far as I would go with everything that I know at this point in time. Maybe one more thing that I would want to add to is that, again, we’re talking about low single digits decline in volumes in the fourth quarter. But with a further improving trajectory, we’re expecting to exit the fourth quarter flat on volumes.

Operator: Your next question comes from the line of Adam Samuelson of Goldman Sachs. Your line is open.

Adam Samuelson: Yes. Thank you. Good afternoon, everyone. I was hoping to maybe talk a little bit about the operating leverage in the business or lack thereof on the deleverage side just given the profit performance, especially in Flexibles relative to the volume and mix declines you still saw in the period. And hoping to maybe just aggregate a little bit the amount of fixed cost reductions actually realized in the period versus the variable cost kind of efficiencies and productivity gains in the quarter and how kind of durable you think those variable costs and productivity improvements proved to be if volumes start to normalize or how much cost would have to leak into the system to serve incremental volumes from here?

Michael Casamento: Thanks for the question, Adam. I’ll take that. It’s Michael here. Yes, look, on the cost side, we’re really pleased with the cost performance of the business in Q3. We took another kind of $130 million out of cost, which included some benefit from the restructuring program that we’ve got in place. So we now are now starting to see that come through. So that was about $15 million, as expected. And if you just take a step back and think about the cost work we’ve been doing, what are we actually doing? There’s two things that we’re focused on. Firstly, the operational side of the business, the cost productivity and cost flexing in a lower volume environment. And then the second is that structural program that we’ve talked about in response to trying to offset some of the divested Russia earnings.

So in the quarter, we saw benefits from both, and we saw that in both the Flexibles and Rigid segment as well. So that was pleasing. And look, on the operational side, what have we been doing, we’ve been really both proactive and aggressive in flexing the cost base. And that’s into account the lower demand environment. So we’ve been certainly eliminating shifts to take labor out where we can, reducing the overtime to take that labor cost out, taking extended shuts when we’re aligning with some of our customers, so we’re going to take extended shuts over long weekends and other things to get the plants fully closed and get the cost out that way. We’re driving procurement. Obviously, in a lower volume environment, that’s also an opportunity for us to drive procurement savings and we’ve been really focused on that, and the team has done really good work there.

And we’ve been tightly controlling our discretionary spend. So that’s kind of on the operating side. And then on the structural side, that’s more about plant closures. So we’ve announced seven plant closures and two restructures. And more recently, we’ve actually completed the closure around three or four of those. So we’ve now started to see that benefit flow through as we anticipated. And that program was going to deliver about a $50 million EBIT benefit over the program, $35 million, predominantly in the second half of FY ‘24 and then another $15 million into FY ‘25. And we’re pleased to report that we are now seeing those benefits come through. And in Q3, that contributed $15 million. The majority of that was in Flexibles, but also a few million in Rigid.

So again, good cost control in both of those areas. And it’s difficult to determine how much of that is going to stick with the business long-term. But I guess what we would say is that we’ve taken a pretty significant head count out of the business. If you think about the structural cost out, I mean, those structural costs that have come out and they’re permanent. So the $50 million over time that comes through will be permanent. I mean on the procurement benefits, they’ll be sustained. The productivity we’d anticipate over the last several quarters, we’ve improved productivity, improved efficiency, being able to do more with less. So again, we’d expect that to continue. But as the volumes come back, we will have to put labor back into the business, rebuild shifts, but it’s not going to be linear.

So we expect that we will continue to see margin improvement. And this will just contribute to Amcor’s ongoing margin enhancement. We typically, over a long period of time, have added 20 to 30 basis points in margin a year. And this program – we’d expect to continue that through the cost measures that we’ve taken here, and you saw that in the quarter. I mean we delivered a 120 basis point increase on the back of volumes improving, but cost take out really strong and the performance there across the business was great. So we feel pretty good about where we’re at. There’s still more cost to come out. You’ll see further benefits from the structural programs in Q4 as well as some ongoing efficiency benefits from the actions we’ve already taken.

Peter Konieczny: And I would add that we’re particularly pleased with the work that’s been done in the Rigid segment here because we acknowledged that the business returned active profit growth in the third quarter on the back of a pretty soft environment still. So that speaks to a good leverage in that business.

Operator: Your next question comes from the line of John Purtell of Macquarie. Your line is open.

John Purtell: Good afternoon, Peter and Michael. I’ll just ask my one. The sequential volume pickup in Flexibles, just from the commentary and the release, so that appeared to mainly come from emerging markets rather than developed markets. So was there much sequential volume improvement in North America and Europe, for example?

Peter Konieczny: Yes, that’s also a great question. So in terms of our country sort of performance or the different regions, you’re right, we saw low single-digit growth in emerging markets in the third quarter, which was obviously pleasing and positive. And on the developed markets, we saw a bigger sequential improvement while we’re still negative in terms of our volume performance versus prior year. Now you got to keep in mind that the bigger markets were the ones that were more heavily hit with inventory builds and now with a normalization, therefore, the destocking. And that would also make sense, particularly with our exposure to healthcare in those markets.

Operator: Your next question comes from the line of Richard Johnson of Jefferies. Your line is open.

Richard Johnson: Thanks, very much. PK, I think I’m right in saying you pretty much worked in every part of the business, except Rigid. I’d be really interested just to get a sense of how you feel about the strategic positioning of the group overall at the moment, but also particularly focusing on Rigid Plastics, which is perhaps in a slightly different position. And with the backdrop of in the beverage market anyway, other substrates appearing to be recovering a lot quicker than plastics.

Peter Konieczny: Yes, Richard, thanks for the question. I mean there is we’re in a particular situation right now with the business. We’ve had a couple of tough quarters behind us with volume weakness. And we’ve worked really hard to position the business as well as possible to take advantage of the volumes improving again. And we believe that’s exactly the situation we’re in right now. So we said in discussing – after discussing the second quarter, we said we feel like the second quarter for the business was below point. And particularly now as we’re having the third quarter an hour back, I think we can confirm that. That’s where we stand. And we believe that we will see a better volume performance in Q4. So that’s the starting point.

In that environment, we felt we want to get, first of all, back to the earnings capacity of the businesses that we have without asking strategic questions about the businesses. And we believe, particularly to Rigid Plastics, you’re right. I’ve been around in Amcor a bit, Rigid Plastics, I’ve not managed myself. But when we look at Rigid Plastics, we think it’s a good business strategically. And I’ll give you a couple of views here from my side. First of all, it’s a scale business. It’s business for Amcor. There’s no question about it. And secondly, when you look at the portfolio of the business, it’s actually a number of different businesses under one roof. We – often, we focus very strong in discussing North American beverage, but it’s more than that.

We have a specialty containers business. So where we started to diversify, we have a Latin American business and we have a closures business with our [indiscernible] business. So it’s a portfolio of businesses. We have really good industry positions. And across Rigids where we participate, we like the customer relationships that we have with good solid customer relationships. And on top of that, also in the overall context of plastic, we have a strong sustainability profile, particularly in that business, which is really important. And finally, I’ll come back to what I said at the beginning. We’ve done a lot of strengthening in the business and the restructuring, for example, with the footprint optimization that we’ve gone through when we’ve generated a leverage that has enabled us to return the business back to profit growth.

So I think where we stand right now is we want to see the volumes come back and then we want to see what the business can deliver. There’s no question that we want the business to deliver more and that’s where I would leave it for now. By the way, I think – I don’t know if you said it’s the Rigid Plastics business or the Rigid Packaging business. Actually, we call the Rigid Packaging business, and it’s just a little clarification. Thank you.

Operator: Your next question comes from the line of James Wilson of Jarden Australia. Your line is open.

James Wilson: Hey, guys. Good morning. Would you be able to just talk us through the net interest guidance that you guys have put out, particularly what’s driving the lower net interest given that leverage looks unchanged in your guidance? I understand that you’ve had some working capital improvements, but are there anything else that’s driving that?

Michael Casamento: Yes. No, thanks for the question. You saw us we reduced slightly the guidance. Our guidance prior to this quarter was $315 million to $330 million, and we reduced that down to $310 million to $320 million. And look, that’s really just on the back of the timing of the cash flows and the working capital improvements. We saw a little better timing of cash coming into the business, which, as we look at the forecast for the fourth quarter, we can see that and see that there’s a little bit of upside there on the interest cost. So we adjusted the guidance range accordingly. But outside of that, there’s not a lot of to it. No real change in the rate profile or the mix of debt.

Operator: Your next question comes from the line of George Staphos of Bank of America. Your line is open.

George Staphos: Good afternoon. Thanks for taking my question. PK, could you give us a bit more color in terms of some of the trends you’re seeing in Flexibles, in cheese and protein and some of the other key markets. And relatedly, are you seeing your customers perhaps pushing back some of their sustainability targets one of the larger branded companies and what are the implications for you in terms of growth as well? Thank you.

Peter Konieczny: Sure. So in Flexibles, again, a pretty significant improvement in volumes between Q2 and Q3. I did make a comment earlier in terms of the two main drivers here: market impact. We are pretty much – were flat in the third quarter and the destocking sort of went to low single digits, and it pretty much is the healthcare impact of destocking that drove the volume decline versus prior year and the balance of the portfolio is pretty much flat to slightly growing. Now in terms of the category performance against that, you would remember that we’re driving a couple of priority categories here in the business where we believe we have really differentiated products and a good position in the market and where we like the market dynamics.